Brief: Initiator Reports Positive Phase IIb Efficacy Data With Pudafensine

Initiator Pharma A/S

06/10/2023 07:16

Oct 6 (Reuters) - Initiator Pharma A/S  INIT.ST :
    * INITIATOR PHARMA REPORTS POSITIVE STATISTICALLY
SIGNIFICANT AND
CLINICALLY RELEVANT PHASE IIB EFFICACY DATA WITH PUDAFENSINE
    * STUDY DATA ANALYSIS HAS DEMONSTRATED STATISTICALLY
SIGNIFICANT
AND CLINICALLY RELEVANT EFFICACY IN ED-RELATED ENDPOINTS AND NO
OBSERVATIONS OF CRITICAL ADVERSE EVENTS

Source text for Eikon:  ID:nMFNbjBkkZ 
Further company coverage:  INIT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))